Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

被引：0
|
作者：
Yasuo Suzuki
Satoshi Motoya
Hiroyuki Hanai
Takayuki Matsumoto
Toshifumi Hibi
Anne M. Robinson
Nael M. Mostafa
Jingdong Chao
Vipin Arora
Anne Camez
Roopal B. Thakkar
Mamoru Watanabe
机构：
[1] Toho University Medical Center Sakura Hospital,IBD Center
[2] Sapporo Kosei General Hospital,Department of Gastroenterology
[3] Hamamatsu South Hospital,undefined
[4] Hyogo College of Medicine,undefined
[5] Kitasato Institute Hospital,undefined
[6] AbbVie,undefined
[7] AbbVie GmbH & Co KG,undefined
[8] Tokyo Medical and Dental University,undefined
来源：
Journal of Gastroenterology | 2014年 / 49卷
关键词：
Clinical remission; Japan; Ulcerative colitis; Mucosal healing; Adalimumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 294
页数：11
相关论文
共 50 条
  • [21] Efficacy and safety of vedolizumab and adalimumab in Asian adults with moderately to severely active ulcerative colitis: Post-hoc analysis of the VARSITY trial
    Kim, J. S.
    Leung, W. K.
    Wu, D. C.
    Lindner, D.
    Fadeeva, O.
    Demuth, D.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S431 - S431
  • [22] Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials
    Zhang, Zong Mei
    Li, Wei
    Jiang, Xue Liang
    GUT AND LIVER, 2016, 10 (02) : 262 - 274
  • [23] 52-WEEK CLINICAL EFFICACY WITH ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO FAILED CORTICOSTEROIDS AND/OR IMMUNOSUPPRESSANTS
    Reinisch, W.
    Sandborn, W. J.
    Kumar, A.
    Pollack, P. F.
    Lazar, A.
    Thakkar, R. B.
    GUT, 2011, 60 : A139 - U2002
  • [24] Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis
    Atsushi Nishida
    Hirotsugu Imaeda
    Masashi Ohno
    Osamu Inatomi
    Shigeki Bamba
    Mitsushige Sugimoto
    Akira Andoh
    Journal of Gastroenterology, 2017, 52 : 476 - 482
  • [25] Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis
    Nishida, Atsushi
    Imaeda, Hirotsugu
    Ohno, Masashi
    Inatomi, Osamu
    Bamba, Shigeki
    Sugimoto, Mitsushige
    Andoh, Akira
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (04) : 476 - 482
  • [26] EFFICACY AND SAFETY OF SINGLE FECAL MICROBIOTA TRANSPLANTATION FOR JAPANESE PATIENTS WITH MILD TO MODERATELY ACTIVE ULCERATIVE COLITIS
    Nishida, Atsushi
    Imaeda, Hirotsugu
    Bamba, Shigeki
    Andoh, Akira
    GASTROENTEROLOGY, 2017, 152 (05) : S574 - S574
  • [27] COST-EFFECTIVENESS OF ADALIMUMAB FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN CANADA
    Ghosh, S.
    Desjardins, O.
    Skup, M.
    Wang, S.
    Yang, M.
    Yang, H.
    Qi, C.
    Bao, Y.
    Chao, J.
    VALUE IN HEALTH, 2014, 17 (03) : A37 - A37
  • [28] Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Chen, Xinlin
    Hou, Jiangtao
    Yuan, Yujie
    Huang, Chaoyuan
    Liu, Tianwen
    Mo, Chuanwei
    Li, Haiwen
    Chen, Bin
    Xu, Qian
    Hou, Zhengkun
    He, Weiling
    Liu, Fengbin
    BIODRUGS, 2016, 30 (03) : 207 - 217
  • [29] Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Xinlin Chen
    Jiangtao Hou
    Yujie Yuan
    Chaoyuan Huang
    Tianwen Liu
    Chuanwei Mo
    Haiwen Li
    Bin Chen
    Qian Xu
    Zhengkun Hou
    Weiling He
    Fengbin Liu
    BioDrugs, 2016, 30 : 207 - 217
  • [30] Golimumab for moderately to severely active ulcerative colitis
    Kedia, Saurabh
    Ahuja, Vineet
    Makharia, Govind K.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (10) : 1273 - 1282
12345